Non-small Cell Lung Cancer with Leptomeningeal Metastases
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer with Leptomeningeal Metastases.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases [Phase 4]
This update covers a Phase 4 trial of lorlatinib in ALK-positive non-small cell lung cancer patients with brain or leptomeningeal metastases…